Purchase Order 75N96022P00171

This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Twinstrand Biosciences Inc., a for-profit company based in Seattle, Washington. The $24,000.00 contract is for the provision of a SEQUENCING UNIVERSAL KIT. The award date was August 26, 2021, with a completion date of September 30, 2021. The contract has no set-aside designation. Twinstrand Biosciences Inc. has a history of securing federal contracts...

The Food and Drug Administration awarded a $49,987.65 firm fixed-price purchase order to Twinstrand Biosciences Inc. on June 27, 2024, for the Twinstrand Duplex Sequencing Mutagenesis Kit. The contract, which carries no set-aside designation, is scheduled for completion by September 25, 2024, with performance taking place at the contractor's facility in Seattle, Washington. Twinstrand Biosciences specializes in advanced DNA sequencing services and genomic research technologies, offering...

This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...

This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...

The U.S. Bureau of Medicine and Surgery awarded a $62,965.40 firm fixed-price purchase order to Biosearch Technologies, Inc. for dual-labeled probes featuring 5' fluorescein amidite (FAM) and 3' labels. The modification to Purchase Order N3239824P0051, awarded on September 11, 2024, updates payment instructions under Federal Acquisition Regulation clause 252.232-7006 to accommodate combo invoice submissions through the Wide Area Workflow (WAWF) electronic system. The work will be performed at...

This is a $149,976.50 firm fixed-price purchase order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Life Technologies Corporation, a for-profit organization, on February 15, 2018. The contract is for the supply of PLATINUM TAQ DNA POL, SPCL, a specialized product for biomedical research and genetic analysis, with a completion date of March 1, 2018. The place of performance is Fort Detrick, MD. No set-aside was used for this award. Life Technologies...

This firm fixed price purchase order for $19,980.00 was awarded by the National Human Genome Research Institute, a civilian federal agency, to Pacific Biosciences of California, Inc. on December 2, 2020. The award is for the delivery of SMRT CELL 8M TRAYS, with a completion date of January 1, 2021. The contract does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing systems. The company has been awarded over...

This is a firm fixed-price BPA call contract awarded by the U.S. Army Criminal Investigation Command to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $92,180.20, is for the procurement of PN4427368 IDENTIFILIER PLUS (CLIN 0018) and has an ultimate completion date of April 27, 2016. The contract has no set-aside designation. As a division of Thermo Fisher Scientific, Life Technologies has provided specialized...

This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...

This is a firm fixed-price purchase order awarded by the Southeast Area of a civilian federal agency to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract, valued at $60,860.55, is for the provision of TWIST 96-PLEX LIBRARY PREP KIT 10X96 SAMPLES. This contract has no set-aside designation. Twist Bioscience has a history of delivering specialized scientific products and services to various federal agencies, including the...